Dolby Laboratories (NYSE:DLB) CMO Sells $647,835.80 in Stock

Dolby Laboratories (NYSE:DLB) CMO Todd Pendleton sold 11,876 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $54.55, for a total transaction of $647,835.80. Following the completion of the transaction, the chief marketing officer owned 41,480 shares in the company, valued at approximately $2,262,734. This trade represents a 22.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Dolby Laboratories Stock Up 1.1%

NYSE:DLB opened at $55.88 on Friday. The firm has a market cap of $5.29 billion, a PE ratio of 22.09 and a beta of 0.86. Dolby Laboratories has a 12 month low of $52.45 and a 12 month high of $77.00. The company’s 50-day moving average price is $59.46 and its two-hundred day moving average price is $63.02.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The firm had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts expect that Dolby Laboratories will post 3.21 EPS for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.6%. Dolby Laboratories’s payout ratio is 56.92%.

Wall Street Analyst Weigh In

DLB has been the topic of a number of recent analyst reports. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research report on Monday, April 27th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Dolby Laboratories presently has an average rating of “Moderate Buy” and an average price target of $90.75.

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of DLB. Norges Bank bought a new stake in shares of Dolby Laboratories during the fourth quarter worth approximately $54,966,000. AQR Capital Management LLC raised its stake in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares during the last quarter. First Trust Advisors LP raised its stake in shares of Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after buying an additional 374,405 shares during the last quarter. Alyeska Investment Group L.P. bought a new stake in shares of Dolby Laboratories during the fourth quarter worth approximately $23,477,000. Finally, Voloridge Investment Management LLC raised its stake in shares of Dolby Laboratories by 2,017.9% during the fourth quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker’s stock worth $20,904,000 after buying an additional 310,130 shares during the last quarter. 58.56% of the stock is owned by institutional investors.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.